Nurtec ODT orally disintegrating tablets blister packaging

Name of Product:

Nurtec® ODT (Rimegepant) orally disintegrating tablets, 75mg 8-Unit Dose blister pack

Hazard:

The recalled prescription drugs must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.

Remedy:

New Instructions

Repair

Recall Date:

March 16, 2023

Units:

About 4.2 million

Description:

This recall involves prescription drugs Nurtec ODT 75 mg orally disintegrating tablets sold in cartons containing one blister card of 8 tablets. The tablets are in a non-child resistant blister card packaged in a carton that includes the name of the product, dosage strength, NDC number and expiration date. The dosage strength and expiration date are printed or stamped on the blister card.

The recall includes the following:

Product Description

Nurtec® ODT (rimegepant) 75mg 8-Unit Dose blister pack

NDC Number

72618-3000-2

Expiration Date

All dates through 6/2026

Remedy:

Consumers should immediately secure the recalled product out of the sight and reach of children and contact Pfizer for a free child resistant pouch to store the product. Once the product is secured, consumers can continue to use it as directed.

Incidents/Injuries:

None reported

Sold At:

Pharmacies nationwide as a prescribed medicine from December 2021 through March 2023. The prices of the product varied based on health insurance terms and other factors.

Manufacturer(s):

Biohaven Pharmaceuticals Inc., of New Haven, Conn. and Pfizer Inc., of New York

Manufactured In:

United States

Recall number:

23-154

Source and more images: CPSC